Venture Capital Deals and Investments
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Venture Capital Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
Melt&Marble Secures €7M Series A to Scale Precision Fermentation
Series AVenture Capital

Melt&Marble Secures €7M Series A to Scale Precision Fermentation

•December 8, 2025
•Dec 8, 2025
0

Participants

Melt Marble

Melt Marble

company

Industrifonden

Industrifonden

investor

Beiersdorf

Beiersdorf

investor

Valio

Valio

investor

Chalmers Ventures

Chalmers Ventures

investor

Catalyze Capital

Catalyze Capital

investor

Fuel Cells and Hydrogen Joint Undertaking

Fuel Cells and Hydrogen Joint Undertaking

investor

Why It Matters

The investment underscores growing confidence in biotech‑derived ingredients as a sustainable alternative to animal and plant fats, reshaping food and cosmetics supply chains. Corporate backers signal market demand for high‑performance, low‑environmental‑impact fats.

Key Takeaways

  • •€7M Series A led by Industrifonden.
  • •Investors include Beiersdorf, Valio, EIC Fund.
  • •Additional €2.5M EIC grant brings total €10M.
  • •Developing fermented designer fats for food and cosmetics.
  • •Funding will scale operations and accelerate R&D.

Pulse Analysis

Precision fermentation is rapidly moving from niche research to mainstream manufacturing, driven by consumer pressure for sustainable ingredients and regulatory incentives for lower carbon footprints. Across Europe, venture capital and public grants are converging to de‑risk the scale‑up of microbial platforms, positioning companies like Melt&Marble at the forefront of a new ingredient economy. By converting simple feedstocks into tailor‑made fats, the firm sidesteps the land‑intensive agriculture and animal‑based processes that dominate traditional supply chains.

Melt&Marble’s technology leverages advanced microbial engineering to produce designer lipids with specific melting points, oxidative stability and nutritional profiles. These custom fats address performance gaps in plant‑based meat analogues and high‑purity personal‑care formulations, where texture, shelf‑life and skin feel are critical. The company’s focus on functional, health‑oriented fats differentiates it from broader bulk‑fat producers, allowing premium pricing and partnership opportunities with brands seeking differentiated product claims.

The €7 million Series A, complemented by a €2.5 million EIC grant, provides the capital needed to expand pilot bioreactors, automate downstream processing, and build a regulatory dossier for food‑grade approvals. Participation from industry giants such as Beiersdorf and Valio signals confidence that fermented fats can replace conventional ingredients at scale. As the market for alternative proteins and clean‑beauty products accelerates, Melt&Marble is poised to capture a growing share of the sustainable fats segment, potentially reshaping ingredient sourcing across multiple consumer categories.

Deal Summary

Swedish biotech Melt&Marble announced a €7 million Series A round led by Industrifonden, with participation from the EIC Fund, Beiersdorf, Valio, Chalmers Ventures and Catalyze Capital. The funding will be used to expand operations and accelerate development of sustainable designer fats for alternative protein and personal care markets.

0

Comments

Want to join the conversation?

Loading comments...